In vivo evidence implicates uncoupling proteins UCP2 and UCP3 in the etiology of type 2 diabetes, in the mitigation of metabolic syndrome, and in reducing cellular damage due to reactive oxygen species. These functions are consistent with an uncoupling role for UCP2 and 3; however data in the literature are mixed in confirming such a role. Moreover, information on regulation of UCP2 and 3 function by nucleotides and fatty acids is lacking. These problems require a thorough biochemical approach, which will be applied in this project by measuring proton flux catalyzed by the purified, recombinant UCP1, 2 and 3 and by measuring proton flux in mitochondria isolated from cells expressing high amounts of UCP2 and 3.
The specific aims are (1) To identify biological compounds that activate UCP-mediated uncoupling; (2) To determine whether native UCP2 and 3 uncouple isolated mitochondria and to reconstitute native UCP2 and 3 activity to validate the properties of the recombinant proteins; (3) To determine inhibitory affinities of UCP1, 2 and 3 for nucleotides and acyl CoA esters; (4) To investigate the relative roles of saturated and unsaturated fatty acids in the transport mechanisms of UCP1, 2 and 3. Studies on the purified proteins will use protocols established in the laboratory for expression, extraction, purification, reconstitution, and assay of UCP1, 2 and 3 function in liposomes. UCP1 is included in these studies as a gold standard for the validity of these techniques; it is the only UCP for which native reconstitutive activity is presently available. Studies on isolated mitochondria will use tissues known to express UCP in high amounts, such as rat lung. Triiodothyronine will be used to stimulate UCP3 expression in rat skeletal muscle, and lipopolysaccharide will be used to stimulate UCP2 expression in spleen and liver. These studies will provide new understanding of the mechanisms of UCP2 and 3 function and regulation and will also resolve mechanistic questions that have been raised about these proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK056273-06
Application #
6683915
Study Section
Metabolism Study Section (MET)
Program Officer
Haft, Carol R
Project Start
1999-08-01
Project End
2007-05-31
Budget Start
2003-08-01
Budget End
2004-05-31
Support Year
6
Fiscal Year
2003
Total Cost
$275,125
Indirect Cost
Name
Portland State University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
052226800
City
Portland
State
OR
Country
United States
Zip Code
97207
Jezek, Petr; Spacek, Tomas; Garlid, Keith et al. (2006) Undecanesulfonate does not allosterically activate H+ uniport mediated by uncoupling protein-1 in brown adipose tissue mitochondria. Int J Biochem Cell Biol 38:1965-74
Jaburek, Martin; Miyamoto, Sayuri; Di Mascio, Paolo et al. (2004) Hydroperoxy fatty acid cycling mediated by mitochondrial uncoupling protein UCP2. J Biol Chem 279:53097-102
Jaburek, Martin; Garlid, Keith D (2003) Reconstitution of recombinant uncoupling proteins: UCP1, -2, and -3 have similar affinities for ATP and are unaffected by coenzyme Q10. J Biol Chem 278:25825-31
Jabyyrek, M; Varecha, M; Jezek, P et al. (2001) Alkylsulfonates as probes of uncoupling protein transport mechanism. Ion pair transport demonstrates that direct H(+) translocation by UCP1 is not necessary for uncoupling. J Biol Chem 276:31897-905
Garlid, K D; Jaburek, M; Jezek, P (2001) Mechanism of uncoupling protein action. Biochem Soc Trans 29:803-6
Garlid, K D; Jabyyrek, M; Jezek, P et al. (2000) How do uncoupling proteins uncouple? Biochim Biophys Acta 1459:383-9
Jabyyrek, M; Varecha, M; Gimeno, R E et al. (1999) Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. J Biol Chem 274:26003-7